(S (S (NP-SBJ (NNS Interferons)) (VP (VBP induce) (NP (ADJP-COOD (ADJP (JJ normal)) (CC and) (ADJP (JJ aberrant))) (NN retinoic-acid) (NNS receptors) (NN type) (NN alpha)) (PP (IN in) (NP (JJ acute) (JJ promyelocytic) (NN leukemia) (NNS cells)))) (: :)) (NP (NP (NN potentiation)) (PP (IN of) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (JJ retinoid-dependent) (NN differentiation) (NNS markers))))) (. .)))
(S (NP-SBJ (NP (NN Treatment)) (PP (IN of) (NP (DT the) (ADJP (ADJP (JJ acute) (JJ promyelocytic)) (PRN (-LRB- -LRB-) (ADJP (NN APL)) (-RRB- -RRB-))) (NN cell) (NN line) (NN NB4))) (PP (IN with) (NP-COOD (NP (NP (NN interferon) (NN alpha)) (PRN (-LRB- -LRB-) (NP (NN IFN-LRB-alpha-RRB-)) (-RRB- -RRB-))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP-COOD (NP (NN IFN-LRB-beta-RRB-)) (CC and) (NP (NP (-NONE- *?*)) (NN gamma))) (, ,)))) (VP (VBZ results) (PP (IN in) (NP (NP (DT an) (VBN increased) (NN expression)) (PP (IN of) (NP (NP (DT the) (NNS transcripts)) (VP (VBG coding) (PP (IN for) (NP-COOD (NP (NP (JJ retinoic-acid) (NN receptor) (NN type) (NN alpha)) (PRN (-LRB- -LRB-) (NP (NN RAR-LRB-alpha-RRB-)) (-RRB- -RRB-))) (CC and) (NP (DT the) (JJ leukemia-specific) (JJ retinoic) (NN acid) (NN receptor) (NN PML-RAR)))))))))) (. .))
(S-COOD (S (NP-SBJ (NP-SBJ (JJ Transcriptional) (NN induction)) (PP (IN of) (NP (DT the) (NP-COOD (NP (NN RAR-LRB-alpha-RRB-)) (CC and) (NP (NN PML-RAR))) (NNS mRNAs)))) (VP (VBZ is) (ADJP-PRD (JJ rapid)))) (CC and) (S (NP-SBJ-19 (PRP it)) (VP (VBZ is) (VP (VBN parallelled) (NP (-NONE- *-19)) (PP (IN by) (NP-LGS (NP (DT an) (NN increase)) (PP (IN in) (NP (DT the) (JJ corresponding) (NNS proteins)))))))) (. .))
(S (NP-SBJ-20 (NP (NN Up-regulation)) (PP (IN of) (NP (NP-COOD (NP (NN RAR-LRB-alpha-RRB-)) (CC and) (NP (NN PML-RAR))) (NN gene) (NN expression))) (PP (IN by) (NP (NN IFN-LRB-alpha-RRB-)))) (VP (VBZ is) (VP (VBN accompanied) (NP (-NONE- *-20)) (PP (IN by) (NP-LGS (NP (DT a) (JJ strong) (NN potentiation)) (PP (IN in) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (CD 2) (JJ retinoid-dependent) (JJ granulocytic) (NNS markers)) (, ,) (FW i.e.) (, ,) (NP-COOD (NP (JJ granulocyte-colony-stimulating) (NN factor) (NN receptor) (NN mRNA)) (CC and) (NP (NN leukocyte) (NN alkaline) (NN phosphatase))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ (NN IFN-LRB-alpha-RRB-)) (VP (VBZ does) (RB not) (VP (VB have) (NP (DT any) (NNS effects)) (PP (IN on) (NP (NP (DT the) (JJ retinoid-dependent) (NN regulation)) (PP (IN of) (NP (DT the) (JJ myeloid) (NN surface) (NNS markers) (NP-COOD (NP (NN CD11b)) (CC and) (NP (NN CD33))))))))) (. .))
(S (NP-SBJ-COOD (NP (NP (DT The) (JJ IFN-dependent) (NN increase)) (PP (IN in) (NP (NN RAR-LRB-alpha-RRB-) (NNS levels)))) (CC and) (NP (NP (DT the) (JJ enhancing) (NN effect)) (PP (IN of) (NP (DT the) (NN cytokine))) (PP (IN on) (NP (JJ retinoid-dependent) (JJ granulocytic) (NNS markers) (NN expression))))) (VP (MD may) (VP (VB be) (NP-PRD (NP (DT a) (NN characteristic)) (PP (IN of) (NP (ADJP (NN PML-RAR) (JJ positive)) (NNS cells)))) (, ,) (SBAR (IN since) (S (NP-SBJ-21 (DT the) (NNS phenomena)) (VP (VBP are) (RB not) (VP (VBN observed) (NP (-NONE- *-21)) (PP (IN in) (NP (NN HL-60) (NNS promyelocytes))))))))) (. .))
(S (NP-SBJ-COOD (NP (NNS Interferons)) (CONJP (RB as) (RB well) (IN as)) (NP (NNS retinoids))) (VP (VBP inhibit) (NP (NP (DT the) (NN growth)) (PP (IN of) (NP (NN NB4) (NNS cells)))) (, ,) (SBAR (IN although) (S (NP-SBJ (NP (DT the) (CD 2) (NNS classes)) (PP (IN of) (NP (NNS compounds)))) (VP (VBP do) (RB not) (ADVP (RB significantly)) (VP (VBP interact) (PP (IN in) (NNS terms) (IN of) (NP (JJ anti-proliferative) (NN activity)))))))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP (VBP suggest) (NP (NP (DT the) (JJ possible) (NN use)) (PP (IN of) (NP (NP (NNS combinations)) (PP (IN between) (NP-COOD (NP (NNS IFNs)) (CC and) (NP (JJ retinoic) (NN acid)))))) (PP (IN in) (NP (NP (DT the) (JJ cyto-differentiating) (NN treatment)) (PP (IN of) (NP (NN APL) (NNS patients))))))) (. .))
